Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Clinical trial NCT07545395 · RECRUITING

Trial details

NCT number: NCT07545395
Sponsor: Suzhou Alphamab Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophilia A or B

Start date: 2026-03-13
Primary completion: 2027-12-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.